The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Prevention of HIV-1 infection with early antiretroviral therapy.
Open accessAbstract
BACKGROUND: Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. METHODS: In nine countries, we enrolled 1763 couples in which one partner was HIV-1-positive and the other was HIV-1-negative; 54% of the subjects were from Africa, and 50% of infected partners were men. HIV-1-infected subjects with CD4 counts between 350 and 550 cells per cubic millimeter were randomly assigned in a 1:1 ratio to receive antiretroviral therapy either immediately (early therapy) or after a decline in the CD4 count or the onset of HIV-1-related symptoms (delayed therapy). The primary prevention end point was linked HIV-1 transmission in HIV-1-negative partners. The primary clinical end point was the earliest occurrence of pulmonary tuberculosis, severe bacterial infection, a World Health Organization stage 4 event, or death. RESULTS: As of February 21, 2011, a total of 39 HIV-1 transmissions were observed (incidence rate, 1.2 per 100 person-years; 95% confidence interval [CI], 0.9 to 1.7); of these, 28 were virologically linked to the infected partner (incidence rate, 0.9 per 100 person-years, 95% CI, 0.6 to 1.3). Of the 28 linked transmissions, only 1 occurred in the early-therapy group (hazard ratio, 0.04; 95% CI, 0.01 to 0.27; P<0.001). Subjects receiving early therapy had fewer treatment end points (hazard ratio, 0.59; 95% CI, 0.40 to 0.88; P=0.01). CONCLUSIONS: The early initiation of antiretroviral therapy reduced rates of sexual transmission of HIV-1 and clinical events, indicating both personal and public health benefits from such therapy. (Funded by the National Institute of Allergy and Infectious Diseases and others; HPTN 052 ClinicalTrials.gov number, NCT00074581.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Therefore, ART not only is beneficial to the health of persons with HIV infection, it also reduces the risk for transmission.”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [94]
The cited source says what the claim attributes to it.
In the citing paper
“In 2011, the randomized controlled trial HPTN 052 demonstrated that, among HIV mixed-status heterosexual couples, HIV antiretroviral therapy (ART) for the infected partner decreased the risk for transmission to the uninfected partner by 96% (94).”
From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [94]
In the citing paper
“As viral non-suppression increases the likelihood of rapid disease progression and onward transmission to sexual partners [4, 5]”
From Associations Between Patterns of Alcohol Use and Viral Load Suppression Amongst Women Living with HIV in South Africa (2021) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Self-citationViral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N. K., Serwadda, D., Li, C., Wabwire‐Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 2,990
Granich, R., Gilks, C. F., Dye, C., Cock, K. M. D., & Williams, B. G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,987
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429411 · Cited by 1,258
Braitstein, P. K. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68337-2 · Cited by 1,106
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., Hogg, R. S., Deeks, S. G., Eron, J. J., Brooks, J. T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807252 · Cited by 1,105
Self-citationDonnell, D. J., Baeten, J. M., Kiarie, J. N., Thomas, K. K., Stevens, W. S., Cohen, C. R., McIntyre, J. A., Lingappa, J. R., & Celum, C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60705-2 · Cited by 970
Montaner, J. S., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., Shannon, K., Harrigan, P. R., Hogg, R. S., Daly, P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60936-1 · Cited by 780
Das, M., Chu, P. L., Santos, G., Scheer, S., Vittinghoff, E., McFarland, W., & Colfax, G. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011068 · Cited by 771
Sterne, J. A. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60612-7 · Cited by 748
Flagged first, then by citations
Research works printed but not linked: 1
- Smith K, 2011, Curr Opin HIV AIDS, 6, 315
Cited by
Sorted by citations
Items 501–600 of 1,024
van Heuvel, Y., Schatz, S., Rosengarten, J. F., & Stitz, J. (2022) · Toxins · doi:10.3390/toxins14020138 · Cited by 127
Phiri, S., Tweya, H. M., van Lettow, M., Rosenberg, N. E., Trapence, C., Tembo, A. K., Kaunda-Khangamwa, B. N., Kasende, F., Kayoyo, V., Cataldo, F., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001357 · Cited by 88
Self-citationPrevention of HIV-1 Infection with Antiretroviral Therapy
Rodger, A. J., Phillips, A. N., & Lundgren, J. D. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1110588 · Cited by 87
Giannou, F. K., Tsiara, C. G., Nikolopoulos, G. K., Talias, M., Benetou, V., Kantzanou, M., Bonovas, S., & Hatzakis, A. (2016) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2016.1102635 · Cited by 85
Formulation and pharmacology of long-acting rilpivirine
Williams, P. E., Crauwels, H. M., & Basstanie, E. D. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000164 · Cited by 86
Antiretrovirals for Primary HIV Prevention: the Current Status of Pre- and Post-exposure Prophylaxis
Krakower, D., Jain, S., & Mayer, K. H. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0253-5 · Cited by 88
Self-citationSpiritual coping predicts CD4-cell preservation and undetectable viral load over four years
Kremer, H., Ironson, G. H., Kaplan, L. M., Stuetzele, R., Baker, N., & FLETCHER, M. A. (2014) · AIDS Care · doi:10.1080/09540121.2014.952220 · Cited by 86
Lippman, S. A., Maman, S., MacPhail, C. L., Twine, R., Peacock, D., Kahn, K., & Pettifor, A. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078208 · Cited by 95
Toward an AIDS-Free Generation
Fauci, A. S., & Folkers, G. K. (2012) · JAMA · doi:10.1001/jama.2012.8142 · Cited by 87
Bisphosphonates for Paget's disease of bone in adults
Corral-Gudino, L., Tan, A. J., del Pino‐Montes, J., & Ralston, S. H. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004956.pub3 · Cited by 86
Lambert-Niclot, S., Tubiana, R., Beaudoux, C., Lefebvre, G., Caby, F., Bonmarchand, M., Naouri, M., Schubert, B., Dommergues, M., Cálvez, V., et al. (2012) · AIDS · doi:10.1097/qad.0b013e328352ae09 · Cited by 86
Rana, A., van den Berg, J. J., Lamy, E., & Beckwith, C. G. (2016) · AIDS Patient Care and STDs · doi:10.1089/apc.2016.0025 · Cited by 86
Temporality and Positive Living in the Age of HIV/AIDS: A Multisited Ethnography
Benton, A., Sangaramoorthy, T., & Kalofonos, I. (2017) · Current Anthropology · doi:10.1086/692825 · Cited by 86
Pace, C. S., Song, R., Ochsenbauer, C., Andrews, C. D., Franco, D., Yu, J., Oren, D. A., Seaman, M. S., & Ho, D. D. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304985110 · Cited by 86
Scaling up antiretroviral therapy in resource-limited settings
Vitória, M., Vella, S., & Ford, N. P. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835b8123 · Cited by 85
Katz, I. T., Dietrich, J. J., Tshabalala, G., Essien, T., Rough, K., Wright, A. A., Bangsberg, D. R., Gray, G., & Ware, N. C. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0920-y · Cited by 85
Nikolopoulos, G. K., Pavlitina, E., Muth, S. Q., Schneider, J. A., Psichοgiou, M., Williams, L. D., Paraskevis, D. N., Sypsa, V., Magiorkinis, G., Smyrnov, P., et al. (2016) · Scientific Reports · doi:10.1038/srep38100 · Cited by 85
Haber, N., Tanser, F. C., Bor, J. H., Naidu, K., Mutevedzi, T., Herbst, K., Porter, K., Pillay, D., & Bärnighausen, T. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(16)30224-7 · Cited by 85
Nnko, S., Kuringe, E., Nyato, D., Drake, M., Casalini, C., Shao, A. F., Komba, A., Baral, S., Wambura, M., & Changalucha, J. M. (2019) · BMC Public Health · doi:10.1186/s12889-018-6362-0 · Cited by 87
Association of schistosomiasis and HIV infections: A systematic review and meta-analysis
Patel, P., Rose, C. E., Kjetland, E. F., Downs, J. A., Mbabazi, P. S., Sabin, K. M., Chege, W., Watts, D. H., & Secor, W. E. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.10.088 · Cited by 85
Will Risk Compensation Accompany Pre-Exposure Prophylaxis for HIV?
Blumenthal, J. S., & Haubrich, R. (2014) · The AMA Journal of Ethic · doi:10.1001/virtualmentor.2014.16.11.stas1-1411 · Cited by 90
Kinuthia, J., Drake, A. L., Matemo, D. N., Richardson, B. A., Zeh, C. E., Osborn, L., Overbaugh, J., McClelland, R. S., & John-Stewart, G. C. (2015) · AIDS · doi:10.1097/qad.0000000000000793 · Cited by 85
Krakower, D., & Mayer, K. H. (2015) · Drugs · doi:10.1007/s40265-015-0355-4 · Cited by 89
Self-citationAbbas, U. L., Glaubius, R. L., Mubayi, A., Hood, G., & Mellors, J. W. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit150 · Cited by 88
Kyongo, J. K., Jespers, V., Goovaerts, O., Míchiels, J., Menten, J., Fichorova, R. N., Crucitti, T., Vanham, G., & Ariën, K. K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043951 · Cited by 86
Advances in biosensing strategies for HIV-1 detection, diagnosis, and therapeutic monitoring
Lifson, M. A., Ozen, M. O., İnci, F., Wang, S., Inan, H., Baday, M., Henrich, T. J., & Demirci, U. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.018 · Cited by 87
The Adolescent Trials Network for HIV/AIDS Interventions, Philbin, M. M., Tanner, A. E., DuVal, A. L., Ellen, J. M., Xu, J., Kapogiannis, B. G., Bethel, J., & Fortenberry, J. D. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0650-6 · Cited by 84
Ryan White HIV/AIDS Program Assistance and HIV Treatment Outcomes
Bradley, H. M., Viall, A. H., WORTLEY, P. M., Dempsey, A., Hauck, H., & Skarbinski, J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ708 · Cited by 84
Pérez‐Matute, P., Pérez‐Martínez, L., Blanco, J. R., & Oteo, J. A. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/493413 · Cited by 84
Prophylactic Effect of Antiretroviral Therapy on Hepatitis B Virus Infection
Gatanaga, H., Hayashida, T., Tanuma, J., & Oka, S. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit145 · Cited by 84
Fetherston, S., Boyd, P., McCoy, C. F., McBride, M. C., Edwards, K.-L., Ampofo, S. A., & Malcolm, K. R. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.12.002 · Cited by 84
Gandara, D. R., Li, T., Lara, P. N., Kelly, K. L., Riess, J. W., Redman, M. W., & Mack, P. C. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.10.001 · Cited by 85
Mucosal Immunity in the Female Genital Tract, HIV/AIDS
Machado, J. R., da Silva, M. V., Cavellani, C. L., dos Reis, M. A., Monteiro, M. L. G. D. R., Teixeira, V. D. P. A., & Corrêa, R. R. M. (2014) · BioMed Research International · doi:10.1155/2014/350195 · Cited by 90
Borges, Á. H., Dubrow, R., & Silverberg, M. J. (2013) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000025 · Cited by 83
(2015) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000466370.86393.d2 · Cited by 83
Sources of HIV incidence among stable couples in sub‐Saharan Africa
Chemaitelly, H. S., Awad, S. F., Shelton, J. D., & Abu-Raddad, L. J. (2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.1.18765 · Cited by 83
Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection
Ndhlovu, Z. M., Kazer, S. W., Nkosi, T., Ogunshola, F. J., Muema, D., Anmole, G., Swann, S. A., Moodley, A., Dong, K. L., Reddy, T., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau0528 · Cited by 81
Magidson, J. F., Joska, J. A., Regenauer, K. S., Satinsky, E., Andersen, L. S., Seitz-Brown, C. J., Borba, C. P. C., Safren, S. A., & Myers, B. (2019) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2018.11.004 · Cited by 80
Phylogenetic inferences on HIV-1 transmission
BRENNER, B. G., Wainberg, M. A., & Roger, M. (2013) · AIDS · doi:10.1097/qad.0b013e32835cffd9 · Cited by 83
Liau, A., Crepaz, N., Lyles, C. M., Higa, D. H., Mullins, M. M., DeLuca, J. B., Petters, S., & Marks, G. N. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0435-y · Cited by 82
Okulicz, J. F., Le, T. D., Agan, B. K., Camargo, J. F., Landrum, M. L., Wright, E., Dolan, M. J., Ganesan, A., Ferguson, T. M., Smith, D. M., et al. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.4010 · Cited by 83
Barnabas, R. V., van Rooyen, H., Tumwesigye, E., Murnane, P. M., Baeten, J. M., Humphries, H., Turyamureeba, B., Joseph, P., Krows, M. L., Hughes, J. P., et al. (2014) · The Lancet HIV · doi:10.1016/s2352-3018(14)70024-4 · Cited by 81
Linkage to and retention in care following healthcare transition from pediatric to adult HIV care
Ryscavage, P., Macharia, T., Patel, D. M., Palmeiro, R., & Tepper, V. J. (2016) · AIDS Care · doi:10.1080/09540121.2015.1131967 · Cited by 82
Walsh, F. J., Bärnighausen, T., Delva, W., Fleming, Y., Khumalo, G., Lejeune, C. L., Mazibuko, S., Mlambo, C. K., Reis, R., Spiegelman, D. L., et al. (2017) · Trials · doi:10.1186/s13063-017-2128-8 · Cited by 84
Mangal, T. D., Meireles, M. V., Pascom, A. R. P., Coelho, R. D. A., Benzaken, A. S., & Hallett, T. B. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3844-3 · Cited by 82
Which Gay Men Would Increase Their Frequency of HIV Testing with Home Self-testing?
Bavinton, B. R., Brown, G., Hurley, M., Bradley, J., Keen, P., Conway, D. P., Guy, R., Grulich, A. E., & Prestage, G. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0450-z · Cited by 82
Impact of Depression and Inflammation on the Progression of HIV Disease
Rivera-Rivera, Y., & Vázquez-Santiago, F. J. (2016) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000423 · Cited by 87
Pantalone, D. W., Nelson, K. M., Batchelder, A. W., Chiu, C., Gunn, H. A., & Horvath, K. J. (2020) · The Journal of Sex Research · doi:10.1080/00224499.2020.1728514 · Cited by 81
Hankins, C. A., Forsythe, S., & Njeuhmeli, E. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001127 · Cited by 81
McMahon, J. M., Myers, J. E., Kurth, A., Cohen, S. E., Mannheimer, S., Simmons, J., Pouget, E. R., Trabold, N., & Haberer, J. E. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2013.0302 · Cited by 87
Incidence rate estimation, periodic testing and the limitations of the mid-point imputation approach
Vandormael, A. M., Dobra, A., Bärnighausen, T., de Oliveira, T., & Tanser, F. C. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx134 · Cited by 80
HIV in Canada—surveillance report, 2019
Haddad, N., Weeks, A., Robert, A., & Totten, S. (2021) · Canada Communicable Disease Report · doi:10.14745/ccdr.v47i01a11 · Cited by 81
Managed Problem Solving for Antiretroviral Therapy Adherence: A Randomized Trial
Gross, R., Bellamy, S. L., Chapman, J., Han, X.-Y., O’Duor, J., Palmer, S., Houts, P., Coyne, J., & Strom, B. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.2152 · Cited by 88
Modelling the Impact of Antiretroviral Therapy on the Epidemic of HIV
Williams, B. G., Lima, V. D., & Gouws, E. (2011) · Current HIV Research · doi:10.2174/157016211798038533 · Cited by 84
Stover, J., Hallett, T. B., Wu, Z., Warren, M., Gopalappa, C., Pretorius, C., Ghys, P. D., Montaner, J. S. G., Schwartländer, B., & the New Prevention Technology Study Group (2014) · PLoS ONE · doi:10.1371/journal.pone.0111956 · Cited by 83
Heterosexual HIV-1 Infectiousness and Antiretroviral Use
Baggaley, R. F., White, R. G., Hollingsworth, T. D., & Boily, M. (2012) · Epidemiology · doi:10.1097/ede.0b013e318276cad7 · Cited by 80
Nunn, A. S., Cornwall, A. H., Chute, N., Sanders, J., Thomas, G. L., James, G., Lally, M., Trooskin, S. B., & Flanigan, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036172 · Cited by 80
Chandler, R. K., Kahana, S. Y., Fletcher, B. W., Jones, D. J., Finger, M. S., Aklin, W. M., Hamill, K., & Webb, C. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302788 · Cited by 80
Universal Testing and Treatment as an HIV Prevention Strategy: Research Questions and Methods
Hayes, R., Sabapathy, K., & Fidler, S. J. (2011) · Current HIV Research · doi:10.2174/157016211798038515 · Cited by 83
Kwarisiima, D., Kamya, M., Owaraganise, A., Mwangwa, F., Byonanebye, D., Ayieko, J., Plenty, A., Black, D., Clark, T., Nzarubara, B., et al. (2017) · Journal of the International AIDS Society · doi:10.7448/ias.20.5.21673 · Cited by 79
Self-citationGive PrEP a chance: moving on from the “risk compensation” concept
Castro, D. R., Delabre, R. M., & Molina, J. (2019) · Journal of the International AIDS Society · doi:10.1002/jia2.25351 · Cited by 85
British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018
Gilleece, Y. C., Tariq, S., Bamford, A., Bhagani, S. R., Byrne, L., Clarke, E., Clayden, P., Lyall, H., Metcalfe, D. R., Palfreeman, A., et al. (2019) · HIV Medicine · doi:10.1111/hiv.12720 · Cited by 84
Girum, T., Yasin, F., Kasahun, A. W., Shumbej, T., Bekele, F., & Zeleke, B. (2020) · AIDS Research and Therapy · doi:10.1186/s12981-020-00274-3 · Cited by 80
ART adherence among men who have sex with men living with HIV: key challenges and opportunities
Quinn, K. G., & Voisin, D. (2020) · Current HIV/AIDS Reports · doi:10.1007/s11904-020-00510-5 · Cited by 62
Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa
Hamers, R. L., Sigaloff, K., Kityo, C. M., Mugyenyi, P. N., & de Wit, T. F. R. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32835b7f94 · Cited by 83
Schwartz, S., Lambert, A., Phaswana-Mafuya, N. R., Kose, Z., Mcingana, M., Holland, C. E., Ketende, S. C., Yah, C. S., Sweitzer, S., Hausler, H., et al. (2016) · Sexually Transmitted Infections · doi:10.1136/sextrans-2016-052773 · Cited by 80
Eakle, R., Bourne, A. H., Mbogua, J., Mutanha, N., & Rees, H. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25081 · Cited by 80
Kapogiannis, B. G., Koenig, L. J., Xu, J., Mayer, K. H., Loeb, J., Greenberg, L., Monte, D., Banks-Shields, M., Fortenberry, J. D., & the Adolescent Medicine Trials Network for HIV/AIDS Interventions (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002308 · Cited by 80
Self-citationYang, H., Wu, H., Hancock, G., Clutton, G., Sande, N., Xu, X., Yan, H., Huang, X., Angus, B., Kuldanek, K., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis379 · Cited by 79
Wachira, J., Kimaiyo, S., Ndege, S., Mamlin, J. J., & Braitstein, P. K. A. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir789 · Cited by 78
Paparini, S., & Rhodes, T. (2016) · Critical Public Health · doi:10.1080/09581596.2016.1140127 · Cited by 79
“Taking a Half Day at a Time:” Patient Perspectives and the HIV Engagement in Care Continuum
Christopoulos, K., Massey, A. D., Lopez, A. M., Geng, E. H., Johnson, M. O., Pilcher, C. D., Fielding, H., & Dawson-Rose, C. S. (2013) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0418 · Cited by 79
Randomized Comparison of Universal and Targeted HIV Screening in the Emergency Department
Lyons, M. S., Lindsell, C. J., Ruffner, A. H., Wayne, D. B., Hart, K. W., Sperling, M. I., Trott, A. T., & Fichtenbaum, C. J. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182a21611 · Cited by 79
Smith, J., Sharma, M., Levin, C., Baeten, J. M., van Rooyen, H., Celum, C., Hallett, T. B., & Barnabas, R. V. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(15)00016-8 · Cited by 79
Nyogea, D., Mtenga, S., Henning, L., Franzeck, F. C., Glass, T. R., Letang, E., Tanner, M., & Geubbels, E. L. P. E. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0753-y · Cited by 79
Solomon, S. S., Mehta, S. H., McFall, A. M., Srikrishnan, A. K., Saravanan, S., Laeyendecker, O. B., Balakrishnan, P., Celentano, D. D., Solomon, S., & Lucas, G. M. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)00019-9 · Cited by 79
Self-citationSexual Behaviors and HIV Status: A Population-Based Study Among Older Adults in Rural South Africa
Rosenberg, M. S., Gómez-Olivé, F. X., Rohr, J. K., Houle, B. C., Kabudula, C. W., Wagner, R. G., Salomon, J. A., Kahn, K., Berkman, L. F., Tollman, S. M., et al. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001173 · Cited by 79
Coutsoudis, A., Goga, A. E., Desmond, C., Barron, P., Black, V., & Coovadia, H. M. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61807-8 · Cited by 78
Fasawe, O., Ávila, C., Shaffer, N., Schouten, E. J., Chimbwandira, F. M., Hoos, D., Nakakeeto, O. N., & Lay, P. R. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057778 · Cited by 78
Delva, W., Wilson, D. P., Abu-Raddad, L. J., Görgens, M., Wilson, D. J., Hallett, T. B., & Welte, A. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001239 · Cited by 79
Rendina, H. J., & Parsons, J. T. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25055 · Cited by 78
Beymer, M. R., DeVost, M. A., Weiss, R. E., Dierst-Davies, R., Shover, C. L., Landovitz, R. J., Beniasians, C., Talan, A. J., Flynn, R. P., Krysiak, R. C., et al. (2018) · Sexually Transmitted Infections · doi:10.1136/sextrans-2017-053377 · Cited by 82
Chikovore, J., Hart, G. J., Kumwenda, M., Chipungu, G. A., & Corbett, E. L. (2015) · Global Health Action · doi:10.3402/gha.v8.26292 · Cited by 78
Mipando, A. L. N., Choko, A. T., Chimwaza, A. F., & Muula, A. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119273 · Cited by 81
Vaccine-Induced Gag-Specific T Cells Are Associated With Reduced Viremia After HIV-1 Infection
Janes, H., Friedrich, D. P., Krambrink, A., Smith, R. J., Kallas, E. G., Horton, H., Casimiro, D. R., Carrington, M. N., Geraghty, D. E., Gilbert, P. B., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit322 · Cited by 79
Regression Discontinuity for Causal Effect Estimation in Epidemiology
Oldenburg, C. E., Moscoe, E., & Bärnighausen, T. (2016) · Current Epidemiology Reports · doi:10.1007/s40471-016-0080-x · Cited by 81
Antiretroviral treatment regardless of CD4 count: the universal answer to a contextual question
Eholie, S. P., Badjé, A., Kouamé, G. M., N’takpe, J.-B., Moh, R., Danel, C., & Anglaret, X. (2016) · AIDS Research and Therapy · doi:10.1186/s12981-016-0111-1 · Cited by 78
Beer, L., Bradley, H. M., Mattson, C. L., Johnson, C. H., Hoots, B., & Shouse, R. L. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001125 · Cited by 78
Earnshaw, V. A., Bogart, L. M., Laurenceau, J., Chan, B. T., Maughan‐Brown, B., Dietrich, J. J., Courtney, I., Tshabalala, G., Orrell, C., Gray, G., et al. (2018) · Journal of the International AIDS Society · doi:10.1002/jia2.25198 · Cited by 78
HIV/AIDS in the South-East Asia region: progress and challenges
Pendse, R., Gupta, S., Yu, D., & Sarkar, S. (2016) · Journal of Virus Eradication · doi:10.1016/s2055-6640(20)31092-x · Cited by 77
Using provider performance incentives to increase HIV testing and counseling services in Rwanda
de Walque, D., Gertler, P., Bautista-Arredondo, S. A., Kwan, A. T., Vermeersch, C. M. J., Bizimana, J. D. D., Binagwaho, A., & Condo, J. U. (2014) · Journal of Health Economics · doi:10.1016/j.jhealeco.2014.12.001 · Cited by 77
Lesko, C. R., Cole, S. R., Zinski, A., Poole, C., & Mugavero, M. J. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit421 · Cited by 77
HIV Prevention 2020: a framework for delivery and a call for action
Dehne, K. L., Dallabetta, G., Wilson, D., Garnett, G. P., Laga, M., Benomar, E., Fakoya, A. O., Baggaley, R. C., Nelson, L. J., Kasedde, S., et al. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)30035-2 · Cited by 83
Bukowski, L. A., Chandler, C. J., Creasy, S. L., Matthews, D. D., Friedman, M. R., & Stall, R. D. (2018) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001831 · Cited by 82
Torres, T. S., Marins, L. M. S., Veloso, V. G., Grinsztejn, B. G. J., & Luz, P. M. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4704-x · Cited by 81
Self-citationFamily Network Proportion and HIV Risk Among Black Men Who Have Sex With Men
Schneider, J. A., Michaels, S., & Bouris, A. M. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318270d3cb · Cited by 78
Feasibility and effectiveness of two community‐based HIV testing models in rural Swaziland
Parker, L. A., Jobanputra, K., Pasipamire, L., Mazibuko, S., Okello, V., Kerschberger, B., Jouquet, G., Cyr, J., & Teck, R. (2015) · Tropical Medicine & International Health · doi:10.1111/tmi.12501 · Cited by 77
Wirtz, A. L., Jumbe, V., Trapence, G., Kamba, D., Umar, E., Ketende, S. C., Berry, M., Strömdahl, S. K., Beyrer, C., & Baral, S. (2013) · Journal of the International AIDS Society · doi:10.7448/ias.16.4.18742 · Cited by 77
Decker, M. R., Wirtz, A. L., Pretorius, C., Sherman, S. G., Sweat, M. D., Baral, S., Beyrer, C., & Kerrigan, D. L. (2013) · American Journal of Reproductive Immunology · doi:10.1111/aji.12063 · Cited by 77
Lourenço, L., Colley, G., Nosyk, B., Shopin, D., Montaner, J. S. G., Lima, V. D., & on behalf of the STOP HIV/AIDS Study Group (2014) · PLoS ONE · doi:10.1371/journal.pone.0115277 · Cited by 77
Metadata
- Authors
- Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., Godbole, S. V., Mehendale, S., Chariyalertsak, S., Santos, B. R., Mayer, K. H., Hoffman, I. F., Eshleman, S. H., Piwowar-Manning, E., Wang, L., Makhema, J., Mills, L. A., de Bruyn, G., Sanne, I., Eron, J., Gallant, J., Havlir, D., Swindells, S., Ribaudo, H., Elharrar, V., Burns, D., Taha, T. E., Nielsen-Saines, K., Celentano, D., Essex, M., & Fleming, T. R.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Fred Hutch Cancer Center (US)
- YR Gaitonde Centre for AIDS Research and Education (IN)
- University of Zimbabwe (ZW)
- Johns Hopkins University (US)
- National AIDS Research Institute (IN)
- Chiang Mai University (TH)
- Fenway Health (US)
- Harvard University (US)
- Kenya Medical Research Institute (KE)
- University of California, San Francisco (US)
- University of Nebraska Medical Center (US)
- National Institutes of Health (US)
- University of Washington (US)
- ORCID
- Cohen, Myron S.
- Chen, Ying Q.
- Gamble, Theresa
- Hosseinipour, Mina C.
- Kumarasamy, Nagalingeswaran
- Hakim, James G.
- Kumwenda, Johnstone
- Grinsztejn, Beatriz
- Godbole, Sheela V.
- Mehendale, Sanjay
- Chariyalertsak, Suwat
- Santos, Breno R.
- Mayer, Kenneth H.
- Hoffman, Irving F.
- Eshleman, Susan H.
- Wang, Lei
- Makhema, Joseph
- Mills, Lisa A.
- Sanne, Ian
- Eron, Joseph
- Gallant, Joel
- Havlir, Diane
- Swindells, Susan
- Ribaudo, Heather
- Burns, David
- Taha, Taha E.
- Celentano, David
- Essex, Max
- Fleming, Thomas R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-08-11
- Volume
- 365
- Issue
- 6
- Pages
- 493-505
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC3200068
- OpenAlex
- W2152505869
- Cited by
- 6,873
- References
- 35
- Citations by year
- 2026: 106 · 2025: 155 · 2024: 189 · 2023: 204 · 2022: 288 · 2021: 354 · 2020: 398 · 2019: 471 · 2018: 510 · 2017: 594 · 2016: 694 · 2015: 720 · 2014: 759 · 2013: 740 · 2012: 571
- FWCI
- 466.60
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
- Funders
- Abbott Laboratories
- Bristol-Myers Squibb
- Pfizer
- GlaxoSmithKline
- Sanofi
- Gilead Sciences
- ViiV Healthcare
- Abbott Diagnostics
- Sanofi Pasteur
- National Institute of Allergy and Infectious Diseases (U01AI068617, U01AI068619, U01AI068613, K24AI051982, UM1AI068619, UM1AI069418, P30AI050410, UM1AI068613, UM1AI068617, P30AI027763)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD042854)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- HIV-1 prevention, early antiretroviral therapy, serodiscordant couples, sexual transmission of HIV, CD4 count, HIV-negative partners, tuberculosis, bacterial infection, AIDS mortality, HPTN 052
- MeSH terms
- Adolescent, Adult, Drug Therapy, Combination, Female, HIV Seropositivity, Humans, Male, Sexual Partners, HIV-1, HIV Infections, Proportional Hazards Models, Treatment Outcome, Disease Progression, Spouses, Disease Transmission, Infectious, Anti-Retroviral Agents, Kaplan-Meier Estimate, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review